Credit Agricole’s PTC Therapeutics PTCT Stock Holding History

Credit Agricole’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.34M	Buy	41,000 +14,684	+56%	+$1.06M	0.01%	839
2026 Q1	$1.79M	Hold	26,316	–	–	﹤0.01%	918
2025 Q4	$2M	Buy	+26,316	New	+$1.91M	﹤0.01%	870
2015 Q4	–	Sell	-5,794	Closed	-$155K	–	1453
2015 Q3	$155K	Buy	+5,794	New	+$248K	﹤0.01%	1326
2015 Q2	–	Sell	-11,228	Closed	-$684K	–	1453
2015 Q1	$684K	Buy	+11,228	New	+$685K	﹤0.01%	1158

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Credit Agricole's PTCT Position: Q2 2026 in Review

Credit Agricole increased its PTC Therapeutics (PTCT) stake by 56% in Q2 2026, buying an estimated $1.06M and bringing the position to 41,000 shares worth $3.34M. The position accounts for 0.01% of the portfolio, ranked #839.

Credit Agricole first reported a position in PTCT in Q1 2015 and has held it in 5 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Credit Agricole held 41,000 shares of PTC Therapeutics worth $3.34M as of Q2 2026.
Credit Agricole bought 14,684 PTC Therapeutics shares in Q2 2026, an estimated $1.06M.
PTC Therapeutics made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #839 holding.
Credit Agricole first reported a position in PTC Therapeutics in Q1 2015 and has held it in 5 quarters since.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.